These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33359140)
1. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency. Dhanalakshmi C; Janakiraman U; Moutal A; Fukunaga K; Khanna R; Nelson MA Neurobiol Dis; 2021 Feb; 149():105224. PubMed ID: 33359140 [TBL] [Abstract][Full Text] [Related]
2. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome. Janakiraman U; Dhanalakshmi C; Yu J; Moutal A; Boinon L; Fukunaga K; Khanna R; Nelson MA Neurobiol Dis; 2020 Sep; 143():105006. PubMed ID: 32622085 [TBL] [Abstract][Full Text] [Related]
3. TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex. Janakiraman U; Yu J; Moutal A; Chinnasamy D; Boinon L; Batchelor SN; Anandhan A; Khanna R; Nelson MA Neurobiol Dis; 2019 Dec; 132():104539. PubMed ID: 31344492 [TBL] [Abstract][Full Text] [Related]
4. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice. Xu J; Yabuki Y; Yu M; Fukunaga K J Pharmacol Sci; 2018 Aug; 137(4):333-341. PubMed ID: 30196018 [TBL] [Abstract][Full Text] [Related]
5. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation. Yabuki Y; Jing X; Fukunaga K Neurochem Int; 2017 Sep; 108():272-281. PubMed ID: 28457878 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of SAK3, a novel T-type voltage-gated Ca Yabuki Y; Matsuo K; Izumi H; Haga H; Yoshida T; Wakamori M; Kakei A; Sakimura K; Fukuda T; Fukunaga K Neuropharmacology; 2017 May; 117():1-13. PubMed ID: 28093211 [TBL] [Abstract][Full Text] [Related]
7. T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice. Wang S; Yabuki Y; Matsuo K; Xu J; Izumi H; Sakimura K; Saito T; Saido TC; Fukunaga K PLoS One; 2018; 13(12):e0206986. PubMed ID: 30571684 [TBL] [Abstract][Full Text] [Related]
8. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice. Yuan D; Cheng A; Kawahata I; Izumi H; Xu J; Fukunaga K Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451040 [TBL] [Abstract][Full Text] [Related]
9. [Role of T-type Calcium Channels in Regulating Neuronal Function]. Yabuki Y Yakugaku Zasshi; 2020; 140(10):1207-1212. PubMed ID: 32999199 [TBL] [Abstract][Full Text] [Related]
10. T-Type Ca Xu J; Kawahata I; Izumi H; Fukunaga K Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181 [TBL] [Abstract][Full Text] [Related]
11. TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish. Gudmundsson S; Wilbe M; Filipek-Górniok B; Molin AM; Ekvall S; Johansson J; Allalou A; Gylje H; Kalscheuer VM; Ledin J; Annerén G; Bondeson ML Sci Rep; 2019 Jul; 9(1):10730. PubMed ID: 31341187 [TBL] [Abstract][Full Text] [Related]
12. TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations. O'Rawe JA; Wu Y; Dörfel MJ; Rope AF; Au PY; Parboosingh JS; Moon S; Kousi M; Kosma K; Smith CS; Tzetis M; Schuette JL; Hufnagel RB; Prada CE; Martinez F; Orellana C; Crain J; Caro-Llopis A; Oltra S; Monfort S; Jiménez-Barrón LT; Swensen J; Ellingwood S; Smith R; Fang H; Ospina S; Stegmann S; Den Hollander N; Mittelman D; Highnam G; Robison R; Yang E; Faivre L; Roubertie A; Rivière JB; Monaghan KG; Wang K; Davis EE; Katsanis N; Kalscheuer VM; Wang EH; Metcalfe K; Kleefstra T; Innes AM; Kitsiou-Tzeli S; Rosello M; Keegan CE; Lyon GJ Am J Hum Genet; 2015 Dec; 97(6):922-32. PubMed ID: 26637982 [TBL] [Abstract][Full Text] [Related]
13. Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders. Crombie EM; Korecki AJ; Cleverley K; Adair BA; Cunningham TJ; Lee WC; Lengyell TC; Maduro C; Mo V; Slade LM; Zouhair I; Fisher EMC; Simpson EM Dis Model Mech; 2024 Jul; 17(7):. PubMed ID: 38804708 [TBL] [Abstract][Full Text] [Related]
14. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611 [TBL] [Abstract][Full Text] [Related]